Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin

Haematologica. 2024 Jul 1;109(7):2364-2367. doi: 10.3324/haematol.2023.284318.

¹ Departement of oncology, Geneva University Hospital, Geneva.
² Laboratory of tumor immunology, Faculty of Medicine and Centre for Translational Research in Onco-Hematology, University of Geneva, Switzerland; Swiss Cancer Centre Léman.
³ SIB Swiss Institute of Bioinformatics.
⁴ Swiss Cancer Centre Léman, Switzerland; Clinical Pathology Service, Geneva University Hospital, Geneva.
⁵ Departement of oncology, Geneva University Hospital, Geneva, Switzerland; Swiss Cancer Centre Léman.
⁶ Departement of oncology, Geneva University Hospital, Geneva, Switzerland; Laboratory of tumor immunology, Faculty of Medicine and Centre for Translational Research in Onco-Hematology, University of Geneva, Switzerland; Swiss Cancer Centre Léman. [email protected].

No abstract available

Publication types